This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Which Stock to Emulate HCA Healthcare (HCA) Success in 2019?
by Zacks Equity Research
While HCA Healthcare (HCA) has been a runaway winner this year, other companies by virtue of strong operating fundamentals are poised for growth in 2019.
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for FYC
Welcome to the Deflation of Asset Prices
by John Blank
At the start of QE, stocks reflated. At the end, they deflated. End of story.
Welcome to the Deflation of Asset Prices
by John Blank
At the start of QE, stocks reflated. At the end, they deflated. End of story.
The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Anthem, Ensign, NeoGenomics, Merit Medical Systems and Medpace
5 Healthcare Bets to Stay in Investors Good Books Next Year
by Zacks Equity Research
Based on a few key factors, we zero in on five stocks that show promise to retain the bull run in 2019.
It's Time for Win-Win Trade Policy: Zacks December Strategy
by John Blank
What of 2019 returns? We shall see. A broad stock valuation re-set (nearing a year in length now) can be a good setup for another broad leg-up and a share price recovery.
Why Is Ensign Group (ENSG) Up 9.8% Since Last Earnings Report?
by Zacks Equity Research
Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FYC
4 Quality Stocks to Counter Market Volatility
by Zacks Equity Research
With the markets currently facing a lot of gyration, investing in quality stocks seems prudent. After all, these stocks provide excellent risk-adjusted returns.
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FYC
Ensign Group's (ENSG) Q3 Earnings Beat Mark, Increase Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) Q3 results gain from solid segmental performances.
Ensign Group (ENSG) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 2.22% and 1.07%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Nursing Homes Industry Outlook: Multiple Challenges Ahead
by Zacks Equity Research
Nursing homes likely to suffer from suppressed revenues, high cost and a shift in care to low-cost settings.
Zacks.com highlights: Matson, Kroger, BG Staffing, Penske Automotive Group and Ensign Group
by Zacks Equity Research
Zacks.com highlights: Matson, Kroger, BG Staffing, Penske Automotive Group and Ensign Group
5 Cheap Market-Beating Dividend Stocks for Your Portfolio
by Sweta Killa
Stocks with a strong history of dividend growth year over year form a healthy portfolio with greater scope of capital appreciation.
Ensign Group (ENSG) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 2.33% and 0.23%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Acquisitions Aid Revenue Growth at Ensign Group (ENSG)
by Zacks Equity Research
Ensign Group's (ENSG) acquisitions over several past years have driven growth.
Ensign Boosts Skilled Nursing Facility With McCall Buyout
by Zacks Equity Research
Ensign's (ENSG) acquisition of McCall reflects its strategy to expand in the growing skilled nursing market.
The Zacks Analyst Blog Highlights: ABIOMED, Lululemon, Insperity, DMC and Ensign
by Zacks Equity Research
The Zacks Analyst Blog Highlights: ABIOMED, Lululemon, Insperity, DMC and Ensign
5 Top Stocks to Buy for the Second Half of 2018
by Tirthankar Chakraborty
With fundamentals remaining strong but risks rising, investors should design their portfolio for the second half in a more conservative manner.
New Strong Buy Stocks for July 2nd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
5 Knockout Stocks to Play the World Cup Fever Pitch
by Ritujay Ghosh
Much like any tournament can't be won without putting up a strong fight, markets too go through ups and downs. Amid all the odds, stock winners leave a mark with their performance.
New Strong Buy Stocks for June 28th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
New Strong Buy Stocks for June 26th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday